PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 105 filers reported holding PULMONX CORP in Q3 2022. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $484,147 | -93.1% | 46,868 | -91.3% | 0.00% | -100.0% |
| Q2 2023 | $7,050,558 | +16.1% | 537,800 | -1.0% | 0.00% | +33.3% |
| Q1 2023 | $6,072,373 | +34.3% | 543,146 | +1.3% | 0.00% | 0.0% |
| Q4 2022 | $4,520,849 | -46.2% | 536,281 | +6.3% | 0.00% | -40.0% |
| Q3 2022 | $8,404,000 | -28.7% | 504,485 | -37.0% | 0.01% | -28.6% |
| Q2 2022 | $11,779,000 | -33.0% | 800,221 | +12.9% | 0.01% | -12.5% |
| Q1 2022 | $17,588,000 | +2181.2% | 708,908 | +2851.2% | 0.01% | – |
| Q4 2021 | $771,000 | -39.8% | 24,021 | -32.5% | 0.00% | -100.0% |
| Q3 2021 | $1,280,000 | +17.1% | 35,593 | +43.6% | 0.00% | 0.0% |
| Q2 2021 | $1,093,000 | +0.7% | 24,784 | +4.5% | 0.00% | 0.0% |
| Q1 2021 | $1,085,000 | +83.0% | 23,724 | +176.2% | 0.00% | – |
| Q4 2020 | $593,000 | – | 8,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $1,003,000 | 6.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,720,901 | $61,990,000 | 1.23% |
| NEXT CENTURY GROWTH INVESTORS LLC | 454,614 | $7,573,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 778,978 | $12,978,000 | 0.75% |
| Novo Holdings A/S | 510,555 | $8,506,000 | 0.41% |
| Champlain Investment Partners, LLC | 2,802,460 | $46,689,000 | 0.32% |
| TimesSquare Capital Management, LLC | 1,223,754 | $20,388,000 | 0.28% |
| Rock Springs Capital Management LP | 597,400 | $9,953,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 29,150 | $486,000 | 0.18% |
| RTW INVESTMENTS, LP | 460,847 | $7,678,000 | 0.18% |